ARCHIVES

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

This article is from The Cancer Letter archive.

Vol. 37 No. 26 | July 1, 2011

Download PDF Visit The Full Archive

Related Articles

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993